SIRT3 and cardiac hypertrophy: Elevated acetyltransferase p300 significantly contributes to SIRT3-deficiency-induced CFR as p300 acetyltransferase specific inhibitor C646 treated SIRT3 deficient mice show improved CFR, ejection fraction, fractional shortening, reduced cardiac hypertrophy, and fibrosis.